科研成果详情

题名MicroRNA-1275 induces radiosensitization in oesophageal cancer by regulating epithelial-to-mesenchymal transition via Wnt/beta-catenin pathway
作者
发表日期2020-01
发表期刊JOURNAL OF CELLULAR AND MOLECULAR MEDICINE   影响因子和分区
语种英语
原始文献类型Article
关键词epithelial-mesenchymal transition miR-1275 oesophageal cancer radioresistance Wnt beta-catenin
其他关键词SQUAMOUS-CELL CARCINOMA ; DNA-DAMAGE ; RADIORESISTANCE ; GROWTH ; PROLIFERATION ; INVASION ; ZEB1 ; EMT ; EXPRESSION ; REPRESSION
摘要Acquired radioresistance is one of the main obstacles for the anti-tumour efficacy of radiotherapy in oesophageal cancer (EC). Recent studies have proposed microRNAs (miRNAs) as important participators in the development of radioresistance in various cancers. Here, we investigated the role of miR-1275 in acquired radioresistance and epithelial-mesenchymal transition (EMT) in EC. Firstly, a radioresistant cell line KYSE-150R was established, with an interesting discovery was observed that miR-1275 was down-regulated in KYSE-150R cells compared to the parental cells. Functionally, miR-1275 inhibition elevated radioresistance in KYSE-150 cells via promoting EMT, whereas enforced expression of miR-1275 increased radiosensitivity in KYSE-150R cells by inhibiting EMT. Mechanically, we demonstrated that miR-1275 directly targeted WNT1 and therefore inactivated Wnt/beta-catenin signalling pathway in EC cells. Furthermore, WNT1 depletion countervailed the promoting effect of miR-1275 suppression on KYSE-150 cell radioresistance through hampering EMT, whereas WNT1 overexpression rescued miR-1275 up-regulation-impaired EMT to reduce the sensitivity of KYSE-150R cells to radiation. Collectively, our findings suggested that miR-1275 suppressed EMT to encourage radiosensitivity in EC cells via targeting WNT1-activated Wnt/beta-catenin signalling, providing a new therapeutic outlet for overcoming radioresistance of patients with EC.
资助项目Natural Science Foundation of China[81602658];Natural Science Foundation of Zhejiang Province[LQ15H160013,LY17H160051];
出版者WILEY
出版地HOBOKEN
ISSN1582-1838
EISSN1582-4934
卷号24期号:1页码:747-759
DOI10.1111/jcmm.14784
页数13
WOS类目Cell Biology ; Medicine, Research & Experimental
WOS研究方向Cell Biology ; Research & Experimental Medicine
WOS记录号WOS:000505309400063
收录类别SCIE ; PUBMED ; SCOPUS
URL查看原文
PubMed ID31733028
PMC记录号PMC6933350
SCOPUSEID2-s2.0-85075143350
通讯作者地址[Su, Huafang]Department of Radiotherapy and Chemotherapy,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,China
Scopus学科分类Molecular Medicine;Cell Biology
引用统计
被引频次:11[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/13966
专题附属第一医院
其他_附属第三医院(瑞安市人民医院)
通讯作者Su, Huafang
作者单位
1.Department of Radiotherapy and Chemotherapy,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,China;
2.Departments of Radiation Oncology,The Third Affiliated Hospital of Wenzhou Medical University,Ruian,China
第一作者单位附属第一医院;  第一临床医学院(信息与工程学院)、附属第一医院
通讯作者单位附属第一医院;  第一临床医学院(信息与工程学院)、附属第一医院
第一作者的第一单位附属第一医院
推荐引用方式
GB/T 7714
Xie, Congying,Wu, Youyi,Fei, Zhenghua,et al. MicroRNA-1275 induces radiosensitization in oesophageal cancer by regulating epithelial-to-mesenchymal transition via Wnt/beta-catenin pathway[J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,2020,24(1):747-759.
APA Xie, Congying, Wu, Youyi, Fei, Zhenghua, Fang, Ya, Xiao, Shenlan, & Su, Huafang. (2020). MicroRNA-1275 induces radiosensitization in oesophageal cancer by regulating epithelial-to-mesenchymal transition via Wnt/beta-catenin pathway. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 24(1), 747-759.
MLA Xie, Congying,et al."MicroRNA-1275 induces radiosensitization in oesophageal cancer by regulating epithelial-to-mesenchymal transition via Wnt/beta-catenin pathway".JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 24.1(2020):747-759.

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Xie, Congying]的文章
[Wu, Youyi]的文章
[Fei, Zhenghua]的文章
百度学术
百度学术中相似的文章
[Xie, Congying]的文章
[Wu, Youyi]的文章
[Fei, Zhenghua]的文章
必应学术
必应学术中相似的文章
[Xie, Congying]的文章
[Wu, Youyi]的文章
[Fei, Zhenghua]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。